Your search returned 7 results.

Results
	1.	Characterization of a high-throughput screening assay for inhibitors of elongation factor p and ribosomal peptidyl transferase activity. [electronic resource] by Swaney, Steven McCroskey, Mark Shinabarger, Dean Wang, Zhigang Turner, Benjamin A Parker, Christian N Producer: 20061113 In: Journal of biomolecular screening vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Examination of edge effects with different storage conditions of preplated dimethyl sulfoxide nanospots in ChemLib 1,536- and 3,456-well assay-ready plates. [electronic resource] by Turner, Benjamin A Evans, Brad P Pearson, Tania T Braden, Timothy K Wise, Scott C Producer: 20090312 In: Assay and drug development technologies vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Multiplexing nuclear receptors for agonist identification in a cell-based reporter gene high-throughput screen. [electronic resource] by Grover, G Scott Turner, Benjamin A Parker, Christian N Meier, Jannika Lala, Deepak S Lee, Paul H Producer: 20040223 In: Journal of biomolecular screening vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Screening and identification of a novel class of TGF-β type 1 receptor kinase inhibitor. [electronic resource] by Huynh, Q Khai Wise, Sarah J Koch, Keith A Castonguay, Laurie A Reid, Brian G Pagratis, Erinn E Koditek, David Glascock, Christopher B Pitts, Kelly R Turner, Benjamin A Liu, Xiaohong Hung, Magdeleine Han, Bin Pagratis, Nikos Producer: 20111212 In: Journal of biomolecular screening vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1. [electronic resource] by Monovich, Lauren Koch, Keith A Burgis, Robin Osimboni, Ekundayo Mann, Thierry Wall, Daniel Gao, Jinhai Feng, Yan Vega, Richard B Turner, Benjamin A Hood, David B Law, Andy Papst, Philip J Koditek, David Chapo, Joseph A Reid, Brian G Melvin, Lawrence S Pagratis, Nikos C McKinsey, Timothy A Producer: 20090813 In: Biochimica et biophysica acta vol. 1789 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2. [electronic resource] by Smith, Bryan D Kaufman, Michael D Leary, Cynthia B Turner, Benjamin A Wise, Scott C Ahn, Yu Mi Booth, R John Caldwell, Timothy M Ensinger, Carol L Hood, Molly M Lu, Wei-Ping Patt, Tristan W Patt, William C Rutkoski, Thomas J Samarakoon, Thiwanka Telikepalli, Hanumaiah Vogeti, Lakshminarayana Vogeti, Subha Yates, Karen M Chun, Lawrence Stewart, Lance J Clare, Michael Flynn, Daniel L Producer: 20160607 In: Molecular cancer therapeutics vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. [electronic resource] by Smith, Bryan D Kaufman, Michael D Lu, Wei-Ping Gupta, Anu Leary, Cynthia B Wise, Scott C Rutkoski, Thomas J Ahn, Yu Mi Al-Ani, Gada Bulfer, Stacie L Caldwell, Timothy M Chun, Lawrence Ensinger, Carol L Hood, Molly M McKinley, Arin Patt, William C Ruiz-Soto, Rodrigo Su, Ying Telikepalli, Hanumaiah Town, Ajia Turner, Benjamin A Vogeti, Lakshminarayana Vogeti, Subha Yates, Karen Janku, Filip Abdul Razak, Albiruni Ryan Rosen, Oliver Heinrich, Michael C Flynn, Daniel L Producer: 20200214 In: Cancer cell vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)